These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 36135715)
21. Role Of Cd8+ Tumour-Infiltrating Lymphocytes In Predicting Regional Lymph Node Metastasis In Lip And Oral Cavity Squamous Cell Carcinoma. Sukhera ZA; Zafar N; Ara N; Muneer S; Haroon A; Saeed Z J Ayub Med Coll Abbottabad; 2023; 35(2):288-293. PubMed ID: 37422823 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value and clinicopathological status of PD-L1 expression and CD8+ TILs in oral squamous cell cancer patients with or without traditional risk factors. Soopanit T; Laokulrath N; Chayopasakul V; Pongsapich W Head Neck; 2023 Apr; 45(4):1017-1025. PubMed ID: 36811208 [TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics. Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471 [TBL] [Abstract][Full Text] [Related]
24. Tumor-stroma ratio is a crucial histological predictor of occult cervical lymph node metastasis and survival in early-stage (cT1/2N0) oral squamous cell carcinoma. Huang S; Cai H; Song F; Zhu Y; Hou C; Hou J Int J Oral Maxillofac Surg; 2022 Apr; 51(4):450-458. PubMed ID: 34412929 [TBL] [Abstract][Full Text] [Related]
25. A retrospective study on the prognostic value of preoperative C-reactive protein to albumin ratio in patients with oral cavity squamous cell carcinoma. Fang KH; Lai CH; Hsu CM; Huang E; Tsai MS; Chang GH; Lee YC; Tsai YT PeerJ; 2020; 8():e9361. PubMed ID: 32587804 [TBL] [Abstract][Full Text] [Related]
26. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients. Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753 [TBL] [Abstract][Full Text] [Related]
27. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma. Kang Y; Zhang Y; Sun Y Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958 [TBL] [Abstract][Full Text] [Related]
28. The systemic inflammation response index predicts the survival of patients with clinical T1-2N0 oral squamous cell carcinoma. Song F; Cai H; Liao Y; Huang S; Jiang Y; Liang J; Xie N; Hou J Oral Dis; 2022 Apr; 28(3):600-610. PubMed ID: 33486833 [TBL] [Abstract][Full Text] [Related]
29. Prognostic implication of CD57, CD16, and TGF-β expression in oral squamous cell carcinoma. Taghavi N; Bagheri S; Akbarzadeh A J Oral Pathol Med; 2016 Jan; 45(1):58-62. PubMed ID: 25808210 [TBL] [Abstract][Full Text] [Related]
30. Investigating the significance of tumor-infiltrating immune cells for the prognosis of lung squamous cell carcinoma. Zhu Y; Zhang X PeerJ; 2019; 7():e7918. PubMed ID: 31667016 [TBL] [Abstract][Full Text] [Related]
31. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages. Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009 [TBL] [Abstract][Full Text] [Related]
32. Prognostic and clinicopathological significance of cytocapsular tubes in oral squamous cell carcinoma. Wang W; Xie N; Yi C; Zhang M; Xiong G; Xu X; Hou J; Wang C J Oral Pathol Med; 2022 Jul; 51(6):520-528. PubMed ID: 35652154 [TBL] [Abstract][Full Text] [Related]
33. Immunoexpression of Tumor Infiltrating Lymphocytes(TILS) CD4 + and CD8 + in Oral Squamous Cell Carcinoma (OSCC) in Correlations with Clinicopathological Characteristics and Prognosis. Wahbi HS; Manadili A Asian Pac J Cancer Prev; 2022 Dec; 23(12):4177-4183. PubMed ID: 36580000 [TBL] [Abstract][Full Text] [Related]
34. Tumor-infiltrating lymphocyte-derived MLL2 independently predicts disease-free survival for patients with early-stage oral squamous cell carcinoma. Zhu N; Ding L; Fu Y; Yang Y; Chen S; Chen W; Zhao M; Zhao X; Lu Z; Ni Y; Hu Q J Oral Pathol Med; 2020 Feb; 49(2):126-136. PubMed ID: 31660637 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of Cd8+ and natural killer cells defense in oral and oropharyngeal squamous cell carcinoma. Santos EM; Rodrigues de Matos F; Freitas de Morais E; Galvão HC; de Almeida Freitas R J Craniomaxillofac Surg; 2019 Apr; 47(4):676-681. PubMed ID: 30803857 [TBL] [Abstract][Full Text] [Related]
36. Identification of an Immune Score-Based Gene Panel with Prognostic Power for Oral Squamous Cell Carcinoma. Huang SN; Li GS; Zhou XG; Chen XY; Yao YX; Zhang XG; Liang Y; Li MX; Chen G; Huang ZG; Dang YW; Li J; Li P; Tang XZ; Rong MH Med Sci Monit; 2020 Jun; 26():e922854. PubMed ID: 32529991 [TBL] [Abstract][Full Text] [Related]
37. Development and validation of a nomogram for the prediction of lymph node metastasis within 2-year postoperatively in cT1-T2N0 oral squamous cell carcinoma. Cheng A; Wang Z; Yuan X; Liu H; Cao W; Wei W; Chang S; Han Z; Guo C; Feng Z Head Neck; 2023 Jan; 45(1):103-114. PubMed ID: 36226586 [TBL] [Abstract][Full Text] [Related]
38. Development and validation of a seven-immune-feature-based prognostic score for oral squamous cell carcinoma after curative resection. Zhou C; Diao P; Wu Y; Wei Z; Jiang L; Zhang W; Li Z; Ye J; Song X; Wu H; Jiang H; Wang Y; Cheng J Int J Cancer; 2020 Feb; 146(4):1152-1163. PubMed ID: 31304591 [TBL] [Abstract][Full Text] [Related]
39. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma. Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828 [TBL] [Abstract][Full Text] [Related]
40. Expansion of CD4+ cytotoxic T lymphocytes with specific gene expression patterns may contribute to suppression of tumor immunity in oral squamous cell carcinoma: single-cell analysis and Chen H; Sameshima J; Yokomizo S; Sueyoshi T; Nagano H; Miyahara Y; Sakamoto T; Fujii S; Kiyoshima T; Guy T; Nakamura S; Moriyama M; Kaneko N; Kawano S Front Immunol; 2023; 14():1305783. PubMed ID: 38077321 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]